Analysis of the functional state of immune cells, evaluated on the basis of the expression levels of checkpoint receptors, revealed that OncoAd treatment decreased the proportion of PD‐1 expression on tumor infiltrated CD8+T cells (Figure 3J). The gene discussed is CD8A; the disease is neoplasm.